445 related articles for article (PubMed ID: 34360999)
1. CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload.
Harjumäki R; Pridgeon CS; Ingelman-Sundberg M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360999
[TBL] [Abstract][Full Text] [Related]
2. Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.
Gopal T; Kumar N; Perriotte-Olson C; Casey CA; Donohue TM; Harris EN; Talmon G; Kabanov AV; Saraswathi V
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G428-G438. PubMed ID: 31928222
[TBL] [Abstract][Full Text] [Related]
3. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
Leung TM; Nieto N
J Hepatol; 2013 Feb; 58(2):395-8. PubMed ID: 22940046
[TBL] [Abstract][Full Text] [Related]
4. The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts.
Linhart K; Bartsch H; Seitz HK
Redox Biol; 2014; 3():56-62. PubMed ID: 25462066
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
Surapaneni KM; Priya VV; Mallika J
Eur Rev Med Pharmacol Sci; 2014; 18(18):2736-41. PubMed ID: 25317811
[TBL] [Abstract][Full Text] [Related]
6. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N
BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663
[TBL] [Abstract][Full Text] [Related]
7. Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
Diesinger T; Buko V; Lautwein A; Dvorsky R; Belonovskaya E; Lukivskaya O; Naruta E; Kirko S; Andreev V; Buckert D; Bergler S; Renz C; Schneider E; Kuchenbauer F; Kumar M; Günes C; Büchele B; Simmet T; Müller-Enoch D; Wirth T; Haehner T
PLoS One; 2020; 15(7):e0235990. PubMed ID: 32701948
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.
Abdelmegeed MA; Ha SK; Choi Y; Akbar M; Song BJ
Curr Mol Pharmacol; 2017; 10(3):207-225. PubMed ID: 26278393
[TBL] [Abstract][Full Text] [Related]
9. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide.
Gergel D; Misík V; Riesz P; Cederbaum AI
Arch Biochem Biophys; 1997 Jan; 337(2):239-50. PubMed ID: 9016819
[TBL] [Abstract][Full Text] [Related]
11. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis.
Nagata K; Suzuki H; Sakaguchi S
J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478
[TBL] [Abstract][Full Text] [Related]
12. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.
Leclercq IA; Farrell GC; Field J; Bell DR; Gonzalez FJ; Robertson GR
J Clin Invest; 2000 Apr; 105(8):1067-75. PubMed ID: 10772651
[TBL] [Abstract][Full Text] [Related]
13. Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease.
Song BJ; Akbar M; Jo I; Hardwick JP; Abdelmegeed MA
Adv Pharmacol; 2015; 74():303-72. PubMed ID: 26233911
[TBL] [Abstract][Full Text] [Related]
14. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role.
Lieber CS
Drug Metab Rev; 2004 Oct; 36(3-4):511-29. PubMed ID: 15554233
[TBL] [Abstract][Full Text] [Related]
15. Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver.
Zeng T; Zhang CL; Zhao N; Guan MJ; Xiao M; Yang R; Zhao XL; Yu LH; Zhu ZP; Xie KQ
Redox Biol; 2018 Apr; 14():295-304. PubMed ID: 28987868
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-4502E1 and Fibrosis.
Mueller S; Peccerella T; Qin H; Glassen K; Waldherr R; Flechtenmacher C; Straub BK; Millonig G; Stickel F; Bruckner T; Bartsch H; Seitz HK
Alcohol Clin Exp Res; 2018 Feb; 42(2):252-259. PubMed ID: 29120493
[TBL] [Abstract][Full Text] [Related]
17. Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.
Bell LN; Molleston JP; Morton MJ; Klipsch A; Saxena R; Vuppalanchi R; Chalasani N
J Clin Gastroenterol; 2011 Oct; 45(9):800-7. PubMed ID: 21602702
[TBL] [Abstract][Full Text] [Related]
18. Chronic Ethanol Consumption and Generation of Etheno-DNA Adducts in Cancer-Prone Tissues.
Peccerella T; Arslic-Schmitt T; Mueller S; Linhart KB; Seth D; Bartsch H; Seitz HK
Adv Exp Med Biol; 2018; 1032():81-92. PubMed ID: 30362092
[TBL] [Abstract][Full Text] [Related]
19. [The role of Cytochrom P4502E1 in Alcoholic Liver Disease and alcohol mediated carcinogenesis].
Seitz HK; Mueller S
Z Gastroenterol; 2019 Jan; 57(1):37-45. PubMed ID: 30641601
[TBL] [Abstract][Full Text] [Related]
20. TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity.
Seth RK; Das S; Dattaroy D; Chandrashekaran V; Alhasson F; Michelotti G; Nagarkatti M; Nagarkatti P; Diehl AM; Bell PD; Liedtke W; Chatterjee S
Free Radic Biol Med; 2017 Jan; 102():260-273. PubMed ID: 27913210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
